Status:
COMPLETED
SZMN Blocks for Pain Control in Pediatric Patients Undergoing T&A
Lead Sponsor:
Stanford University
Conditions:
Postoperative Pain
Opioid Use
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe and effective regional technique for pain management following cleft palate procedures, however, have not been studied for p...
Detailed Description
Patients between 6 months and 18 years undergoing T\&A surgical procedures will be reviewed for potential study enrollment. If participants agree to participate, they will be randomized into either th...
Eligibility Criteria
Inclusion
- Ages 0-18
- Give consent/parental consent to participate in study
- Patients undergoing tonsillectomy and adenoidectomy
Exclusion
- Participants who do not consent or have parental consent
- Patients who are clinically unstable or require urgent/emergent intervention
- Patients under age 6 months
Key Trial Info
Start Date :
November 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 19 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04797559
Start Date
November 29 2021
End Date
April 19 2023
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lucille Packard Children's Hospital
Palo Alto, California, United States, 94304